Chondrocyte hypertrophy is known to be controlled by a complex regulatory network consisting of different markers; among them, Runx2 is a key factor whose overexpression has been largely implicated in the progression of degenerative cartilage affections, such as osteoarthritis and bone remodeling defects. The gene discussed is RUNX2; the disease is osteoarthritis.